Engineering a potent boron-10-enriched polymeric nanoparticle for boron neutron capture therapy.

Background: Boron neutron capture therapy (BNCT) is a promising cancer treatment that eliminates tumor cells by triggering high-energy radiation within cancer cells. Aim: In vivo evaluation of poly(vinyl alcohol)/boric acid crosslinked nanoparticles (PVA/BA NPs) for BNCT. Materials & methods: PVA/BA NPs were synthesized and intravenously injected into tumor-bearing mice for BNCT. Results: The in vitro boron uptake of PVA/BA NPs in tumor cells was 70-fold higher than the required boron uptake for successful BNCT. In an in vivo study, PVA/BA NPs showed a 44.29% reduction in tumor size compared with clinically used boronophenylalanine for oral cancer in a murine model. Conclusion: PVA/BA NPs exhibited effective therapeutic results for oral cancer treatments in BNCT.

[1]  Wei‐Jen Chan,et al.  Nanomedicine in boron neutron capture therapy for cancer treatment: opportunities, challenges and future perspectives. , 2021, Nanomedicine.

[2]  A. Arena,et al.  Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments , 2021, International journal of molecular sciences.

[3]  Kehan Chen,et al.  Nanoparticles: A New Approach to Upgrade Cancer Diagnosis and Treatment , 2021, Nanoscale Research Letters.

[4]  M. Mahmoudi,et al.  Interdependency of influential parameters in therapeutic nanomedicine , 2021, Expert opinion on drug delivery.

[5]  F. Tseng,et al.  Boron-enriched polyvinyl-alcohol/boric-acid nanoparticles for boron neutron capture therapy. , 2021, Nanomedicine.

[6]  Mayya Alexandrovna Dymova,et al.  Boron neutron capture therapy: Current status and future perspectives , 2020, Cancer communications.

[7]  W. Zhou,et al.  Effect of Poly(ethylene glycol) (PEG) Surface Density on the Fate and Antitumor Efficacy of Redox-Sensitive Hybrid Nanoparticles. , 2020, ACS biomaterials science & engineering.

[8]  R. Ferris,et al.  Immunotherapy for head and neck cancer: Recent advances and future directions. , 2019, Oral oncology.

[9]  M. Xie,et al.  Role of hypoxia in cancer therapy by regulating the tumor microenvironment , 2019, Molecular Cancer.

[10]  Minoru Suzuki.  Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era , 2019, International Journal of Clinical Oncology.

[11]  R. Orecchia,et al.  Modern radiotherapy for head and neck cancer. , 2019, Seminars in oncology.

[12]  P. Secchiero,et al.  Actively targeted nanocarriers for drug delivery to cancer cells , 2019, Expert opinion on drug delivery.

[13]  D M Parkin,et al.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.

[14]  F. Chou,et al.  Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor , 2018, Cancer communications.

[15]  D. Ferrari,et al.  Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review , 2018, Medical Oncology.

[16]  Desiree Van Haute,et al.  Challenges in realizing selectivity for nanoparticle biodistribution and clearance: lessons from gold nanoparticles. , 2017, Therapeutic delivery.

[17]  M. Cataldi,et al.  Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes , 2017, International journal of molecular sciences.

[18]  Kamel R. Shoueir,et al.  Biocompatible poly(vinyl alcohol) nanoparticle-based binary blends for oil spill control. , 2016, Marine pollution bulletin.

[19]  B. Jeremic,et al.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Xin Wang,et al.  Phenylboronic Acid-Mediated Tumor Targeting of Chitosan Nanoparticles , 2016, Theranostics.

[21]  S. Miyatake,et al.  Boron Neutron Capture Therapy for Malignant Brain Tumors , 2016, Neurologia medico-chirurgica.

[22]  O. Pearce,et al.  Sialic acids in cancer biology and immunity. , 2016, Glycobiology.

[23]  A. Paetau,et al.  Biodistribution of boron after intravenous 4-dihydroxyborylphenylalanine-fructose (BPA-F) infusion in meningioma and schwannoma patients: A feasibility study for boron neutron capture therapy. , 2015, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[24]  A. Azab,et al.  Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy , 2015, Pharmaceutical Research.

[25]  Hyun-Jong Cho,et al.  Phenylboronic Acid‐Decorated Chondroitin Sulfate A‐Based Theranostic Nanoparticles for Enhanced Tumor Targeting and Penetration , 2015 .

[26]  G. Adema,et al.  Sweet escape: sialic acids in tumor immune evasion. , 2014, Biochimica et biophysica acta.

[27]  E. Holliday,et al.  Proton radiation therapy for head and neck cancer: a review of the clinical experience to date. , 2014, International journal of radiation oncology, biology, physics.

[28]  T. Gorlia,et al.  Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential. , 2010, The British journal of radiology.

[29]  H. Ichikawa,et al.  Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[30]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.

[31]  J. Scherrmann,et al.  CNS Delivery Via Adsorptive Transcytosis , 2008, The AAPS Journal.

[32]  L. Collette,et al.  Uptake of two 10B‐compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001) , 2007, International journal of cancer.